Recent advances of NEAT1-miRNA interactions in cancer

Acta Biochim Biophys Sin (Shanghai). 2022 Feb 25;54(2):153-162. doi: 10.3724/abbs.2021022.

Abstract

With high incidence rate, cancer is the main cause of death in humans. Non-coding RNAs, as novel master regulators, especially long non-coding RNAs (lncRNAs) and microRNAs (miRNAs), play important roles in the regulation of tumorigenesis. lncRNA NEAT1 has recently gained much attention, as it is dysregulated in a broad spectrum of cancers, where it acts as either an oncogene or a tumor suppressor gene. Accumulating evidence shows that NEAT1 is correlated with the process of carcinogenesis, including proliferation, invasion, survival, drug resistance, and metastasis. NEAT1 is considered to be a biomarker and a novel therapeutic target for the diagnosis and prognosis of different cancer types. The mechanisms by which NEAT1 plays a critical role in cancers are mainly via interactions with miRNAs. NEAT1-miRNA regulatory networks play significant roles in tumorigenesis, which has attracted much attention from researchers around the world. In this review, we summarize the interaction of NEAT1 with miRNAs in the regulation of protein-coding genes in cancer. A better understanding of the NEAT1-miRNA interactions in cancer will help develop new diagnostic biomarkers and therapeutic approaches.

Keywords: NEAT1; cancer; ceRNA; interaction; miRNA.

Publication types

  • Review

MeSH terms

  • Carcinogenesis / genetics
  • Humans
  • MicroRNAs* / genetics
  • Neoplasms* / genetics
  • RNA, Long Noncoding* / genetics

Substances

  • MicroRNAs
  • NEAT1 long non-coding RNA, human
  • RNA, Long Noncoding

Grants and funding

This work was in part supported by the grant from the National Natural Science Foundation of China (No. 8197033814).